2-Methylpropane-2-sulfonyl Chloride - CAS 10490-22-9
Catalog: |
BB060322 |
Product Name: |
2-Methylpropane-2-sulfonyl Chloride |
CAS: |
10490-22-9 |
Synonyms: |
2-Methyl-2-propanesulfonyl Chloride; tert-Butylsulfonyl Chloride |
IUPAC Name: | 2-methylpropane-2-sulfonyl chloride |
Description: | 2-METHYLPROPANE-2-SULFONYL CHLORIDE (cas# 10490-22-9) is used as a reagent in the preparation of sulfonamido bicyclopentanyl- dihydroimidazole carboxamides for treatment and prophylaxis of diseases. It also serves as a catalytic. |
Molecular Weight: | 156.63 |
Molecular Formula: | C4H9O2SCl |
Canonical SMILES: | CC(C)(C)S(=O)(=O)Cl |
InChI: | InChI=1S/C4H9ClO2S/c1-4(2,3)8(5,6)7/h1-3H3 |
InChI Key: | WFBUQJSXXDVYFZ-UHFFFAOYSA-N |
References: | Rogers, M., et al. PCT Int. Appl. 123pp. (2020); Quintero, L., et al. e-EROS (2001). |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 20191007 |
WO-2021030238-A2 | Method of synthesis of compound for dual inhibition of jak2 and bet | 20190809 |
CN-111349027-A | Synthesis method of 1, 2-bis [ (trifluoromethyl) sulfonyloxy ] ethane | 20181221 |
CN-108409615-B | Method for synthesizing enantiopure tert-butyl sulfenamide | 20180511 |
CN-108467353-B | Preparation method of enantiopure tert-butyl sulfinamide | 20180511 |
CN-108558715-B | Method for preparing enantiopure tert-butyl sulfenamide | 20180511 |
CN-108129366-B | Antiviral compounds, methods of preparation and uses thereof | 20171108 |
RU-2742234-C1 | Coumarin-like cyclic compound as mek inhibitor and use thereof | 20170623 |
EP-3626703-A1 | Novel compound and pharmaceutical composition comprising same as active ingredient | 20170516 |
KR-20200005621-A | New compounds and pharmaceutical compositions comprising them as active ingredients | 20170516 |
PMID | Publication Date | Title | Journal |
19330098 | 20081201 | Correlation of the rates of solvolysis of two arenesulfonyl chlorides and of trans-beta-styrenesulfonyl chloride - precursors in the development of new pharmaceuticals | International journal of molecular sciences |
19325793 | 20080501 | Concerted solvent processes for common sulfonyl chloride precursors used in the synthesis of sulfonamide-based drugs | International journal of molecular sciences |
Complexity: | 158 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 156.0011784 |
Formal Charge: | 0 |
Heavy Atom Count: | 8 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 156.0011784 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 42.5Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS